Cargando…

The Role of Epigenetics in Primary Biliary Cholangitis

Primary Biliary Cholangitis (PBC) is a rare autoimmune disease of the liver, affecting mostly females. There is evidence that epigenetic changes have a pathogenic role in PBC. Epigenetic modifications are related to methylation of CpG DNA islands, post-translational modifications of histone proteins...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerussi, Alessio, Paraboschi, Elvezia Maria, Cappadona, Claudio, Caime, Chiara, Binatti, Eleonora, Cristoferi, Laura, Asselta, Rosanna, Invernizzi, Pietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105933/ https://www.ncbi.nlm.nih.gov/pubmed/35563266 http://dx.doi.org/10.3390/ijms23094873

Ejemplares similares

LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

New insights on the role of human leukocyte antigen complex in primary biliary cholangitis
por: Mulinacci, Giacomo, et al.
Publicado: (2022)

Genetic susceptibility to severe COVID-19
por: Cappadona, Claudio, et al.
Publicado: (2023)

Comment on “Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis”
por: Cristoferi, Laura, et al.
Publicado: (2020)

Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis
por: Overi, Diletta, et al.
Publicado: (2022)

A National Hospital‐Based Study of Hospitalized Patients With Primary Biliary Cholangitis
por: Manno, Valerio, et al.
Publicado: (2019)

The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities
por: Binatti, Eleonora, et al.
Publicado: (2022)

Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison
por: Montali, Lorenzo, et al.
Publicado: (2021)

Artificial intelligence for precision medicine in autoimmune liver disease
por: Gerussi, Alessio, et al.
Publicado: (2022)

Fibrinogen as a Pleiotropic Protein Causing Human Diseases: The Mutational Burden of Aα, Bβ, and γ Chains
por: Paraboschi, Elvezia Maria, et al.
Publicado: (2017)

Hereditary Hypofibrinogenemia with Hepatic Storage
por: Asselta, Rosanna, et al.
Publicado: (2020)

Primary Sclerosing Cholangitis: Burden of Disease and Mortality Using Data from the National Rare Diseases Registry in Italy
por: Carbone, Marco, et al.
Publicado: (2020)

Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease?
por: Mulinacci, Giacomo, et al.
Publicado: (2021)

ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy
por: Asselta, Rosanna, et al.
Publicado: (2020)

Understanding the Impact of Aberrant Splicing in Coagulation Factor V Deficiency
por: Paraboschi, Elvezia Maria, et al.
Publicado: (2019)

Interpreting Non-coding Genetic Variation in Multiple Sclerosis Genome-Wide Associated Regions
por: Paraboschi, Elvezia Maria, et al.
Publicado: (2018)

Real-world experience with obeticholic acid in patients with primary biliary cholangitis
por: D’Amato, Daphne, et al.
Publicado: (2021)

Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut‐Off Approach
por: Cristoferi, Laura, et al.
Publicado: (2021)

The Characterization of GSDMB Splicing and Backsplicing Profiles Identifies Novel Isoforms and a Circular RNA That Are Dysregulated in Multiple Sclerosis
por: Cardamone, Giulia, et al.
Publicado: (2017)

Genetic Association and Altered Gene Expression of CYBB in Multiple Sclerosis Patients
por: Cardamone, Giulia, et al.
Publicado: (2018)

Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists
por: Abenavoli, Ludovico, et al.
Publicado: (2020)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs
por: Cordell, Heather J., et al.
Publicado: (2021)

Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis
por: Lleo, Ana, et al.
Publicado: (2016)

Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis
por: Parés, Albert, et al.
Publicado: (2020)

Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis
por: Lleo, Ana, et al.
Publicado: (2016)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Meta-Analysis of Multiple Sclerosis Microarray Data Reveals Dysregulation in RNA Splicing Regulatory Genes
por: Paraboschi, Elvezia Maria, et al.
Publicado: (2015)

Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren’s Syndrome and Primary Biliary Cholangitis
por: Arvaniti, Pinelopi, et al.
Publicado: (2019)

New Therapeutic Targets in Autoimmune Cholangiopathies
por: Gerussi, Alessio, et al.
Publicado: (2020)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2019)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

Coronavirus Disease 2019 in Autoimmune Hepatitis: A Lesson From Immunosuppressed Patients
por: Gerussi, Alessio, et al.
Publicado: (2020)

Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial
por: Jones, David, et al.
Publicado: (2023)

Extrahepatic Manifestations of Primary Biliary Cholangitis
por: Chalifoux, Sara L, et al.
Publicado: (2017)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Current understanding of primary biliary cholangitis
por: Tanaka, Atsushi
Publicado: (2021)

Primary biliary cholangitis: pathogenic mechanisms
por: Prieto, Jesús, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6btlvc0rn4mj4i3hqft9r048u8